8-K: Kindly MD Advances Annual Shareholder Meeting Date

Kindly MD, Inc. announced the advancement of its 2025 Annual Shareholder Meeting to December 17, 2025, setting new deadlines for stockholder proposals and director nominations.

Summary

• Kindly MD, Inc.'s Board of Directors established December 17, 2025, as the date for the 2025 Annual Meeting of Stockholders.
• The record date for determining stockholders entitled to receive notice of and vote at the 2025 Annual Meeting is October 23, 2025.
• The meeting will be a virtual meeting conducted by live webcast on the internet.
• The date of the 2025 Annual Meeting is being advanced by more than 30 calendar days from the anniversary of Kindly's prior annual meeting held on November 8, 2024.
• The new deadline for stockholder proposals and director nominations for the 2025 Annual Meeting is October 6, 2025.
• Stockholder proposals must meet the requirements set forth in the rules and regulations of the SEC and Kindly's Second Amended and Restated Bylaws.
• Stockholders intending to solicit proxies for director nominees other than Kindly's must provide notice by October 6, 2025, as required by Rule 14a-19 under the Exchange Act and Kindly's Second Amended and Restated Bylaws.
• Stockholder written proposals should be delivered to Kindly, MD Inc., c/o General Counsel, 5097 South 900 East, Suite 100, Salt Lake City, Utah 84117.
• Kindly disseminates material information through its websites (kindlymd.com, nakamoto.com), press releases, SEC filings, and social media accounts, including those of its Chief Executive Officer, David Bailey.

Sentiment

Score: 5

Explanation: The filing is an administrative update regarding the annual shareholder meeting, which is a neutral event. It provides necessary information for shareholders but does not contain inherently positive or negative financial or operational news.

Positives

• The company is proactively setting the annual meeting date, ensuring corporate governance processes continue.
• Clear deadlines have been provided for shareholder participation in the upcoming annual meeting.

Negatives

• The advancement of the annual meeting date requires shareholders to adjust their timelines for submitting proposals and director nominations, potentially shortening the preparation period.

Risks

• Stockholder proposals or director nominations received after the October 6, 2025 deadline will be considered untimely and will not be included in the proxy materials for the 2025 Annual Meeting nor considered at the meeting.

Future Outlook

Additional details regarding the 2025 Annual Meeting, including the specific time and matters to be voted upon, will be set forth in Kindly's definitive proxy statement, which will be filed with the U.S. Securities and Exchange Commission.

Management Comments

• Kindly encourages investors and others to review the information we make public in the locations below as such information could be deemed to be material information.

Industry Context

This is a standard administrative update for a publicly traded company, ensuring compliance with SEC regulations regarding shareholder meetings and proxy solicitations. The decision to hold a virtual meeting aligns with modern corporate governance practices, which often leverage technology to enhance shareholder accessibility and participation.

Comparison to Industry Standards

• Holding an annual shareholder meeting is a fundamental corporate governance requirement for all publicly traded companies, aligning with global benchmarks for transparency and shareholder rights.
• The provision for virtual meetings is a common practice adopted by many companies, such as Microsoft and Apple, to enhance accessibility for shareholders globally, especially since the COVID-19 pandemic.
• Setting clear deadlines for shareholder proposals and director nominations is standard practice, comparable to guidelines followed by companies like ExxonMobil or Johnson & Johnson, ensuring orderly meeting procedures and compliance with SEC Rule 14a-8 and Rule 14a-19.

Corporate Governance

Stakeholder Impact

• Shareholders: Must note the new annual meeting date and the accelerated deadlines for submitting proposals and director nominations. They will need to review the upcoming definitive proxy statement for full details on meeting time and agenda.
• Management/Board: Responsible for preparing and filing the definitive proxy statement and conducting the virtual annual meeting in accordance with the new schedule and regulatory requirements.

Next Steps

• Kindly will file its definitive proxy statement for the 2025 Annual Meeting with the SEC, detailing the time and matters to be voted upon.
• Stockholders must submit any qualified proposals or director nominations by October 6, 2025, to be considered for the 2025 Annual Meeting.

Key Dates

Keywords

Kindly MD, NAKA, annual meeting, shareholder meeting, proxy statement, stockholder proposals, director nominations, corporate governance, SEC filing, Form 8-K